LONDON--(BUSINESS WIRE)--Closed Loop Medicine Ltd., a leading TechBio company leveraging AI, machine learning, and personalized dosing to enhance drug development, today announced the appointment of Luba Greenwood as Chair of its Board of Directors.

伦敦--（商业新闻短讯）--Closed Loop Medicine Ltd.是一家领先的TechBio公司，利用人工智能、机器学习和个性化给药来促进药物开发，今天宣布任命Luba Greenwood为董事会主席。

Luba is a distinguished executive and investor with over 20 years’ experience in healthcare and tech. She has led over $10 billion USD in deals and investment over multiple therapeutic areas, leading success and scaling companies across the life sciences, medical devices, diagnostics, and tech sectors, including co-founding biotech and digital companies in the immunotherapy, women’s health, AI/ML and microbiome space.

Luba是一位杰出的高管和投资者，在医疗保健和技术领域拥有20多年的经验。她在多个治疗领域的交易和投资中领导了超过100亿美元的交易和投资，在生命科学、医疗器械、诊断和技术领域领先取得了成功并扩大了规模，包括在免疫疗法、女性健康、AI/ML和微生物组领域共同成立的生物技术和数字公司。

Leveraging broad corporate experience alongside legal and technical expertise, Luba’s appointment to Closed Loop Medicine’s Board will be instrumental in supporting development of the Company’s partnering and growth outside of the UK..

凭借广泛的企业经验以及法律和技术专业知识，Luba被任命为闭环医学董事会成员将有助于支持公司在英国以外的合作和发展。。

Luba is currently the Managing Partner of Binney Street Capital (BSC), a venture fund she founded at the Dana-Farber Cancer Institute and has previously served as CEO and Chair of Kojin Therapeutics, a company developing small-molecule therapeutics for a wide range of diseases. She has previously held leadership roles at Google Life Sciences (Verily) and as Vice President of Global Business Development and M&A at Roche, where she established the East Coast Innovation Hub.

Luba目前是Binney Street Capital（BSC）的管理合伙人，Binney Street Capital是她在Dana Farber癌症研究所成立的一家风险基金，此前曾担任Kojin Therapeutics的首席执行官和主席，Kojin Therapeutics是一家开发针对多种疾病的小分子治疗剂的公司。此前，她曾在谷歌生命科学（Verily）担任领导职务，并在罗氏（Roche）担任全球业务发展和并购副总裁，在那里她建立了东海岸创新中心。

Luba is a former lawyer with deep understanding of corporate governance and regulatory, policy, and intellectual property across the pharmaceutical, biotechnology, and technology industries..

Luba曾是一名律师，对制药、生物技术和技术行业的公司治理、监管、政策和知识产权有着深刻的理解。。

Luba has served on the Boards and as an advisor to numerous private and publicly-traded companies, including Abcam, spearheading the sale to Danaher in 2023, and the non-profit Massachusetts Biotechnology Council (MassBio).

卢巴曾担任董事会成员，并担任众多私人和上市公司的顾问，包括Abcam，2023年率先将其出售给Danaher，以及非营利的马萨诸塞州生物技术委员会（MassBio）。

The news follows in a series of high-profile appointments to Closed Loop Medicine’s Board, including digital healthcare leader, Paul Johnson, founder and former CEO of Lemonaid Health, as Non-Executive Director in May 2024, and David Van Sickle, former CEO and Co-Founder of Propeller Health, a digital health and medtech company that launched one of the first integrated software and device combination interventions transforming respiratory disease.

此前，闭环医学董事会（Closed Loop Medicine's Board）进行了一系列备受瞩目的任命，其中包括数字医疗领导者保罗·约翰逊（PaulJohnson），他是柠檬水健康公司（Lemonaid Health）的创始人兼前首席执行官，于2024年5月出任非执行董事，以及大卫·凡·西克尔（David Van Sickle），他是螺旋桨健康公司（Propeller Health）的前首席执行官兼联合创始人。螺旋桨健康公司是一家数字健康和医疗技术公司，推出了首批综合软件和设备组合干预。

Luba’s appointment as Chair demonstrates another integral stage in the Company’s strategy as it prepares for breakthrough milestones in the progression and commercialization of its product pipeline..

Luba被任命为主席，这表明公司战略的另一个不可分割的阶段，因为它正在为产品线的进展和商业化的突破性里程碑做准备。。

Luba Greenwood, Chair of the Board of Closed Loop Medicine, commented: “By catalyzing the development of more precise therapeutics across vast disease areas, Closed Loop’s platform has the potential to not only improve drug safety and efficacy, but transform the way healthcare is delivered.” She added: “The work I do—and have been doing—has been driven by my dedication to bringing innovative products to market and ultimately to patients.

闭环医学委员会主席卢巴·格林伍德（Luba Greenwood）评论道：“通过催化在广大疾病领域开发更精确的治疗方法，闭环平台不仅有可能提高药物的安全性和有效性，而且有可能改变医疗保健的提供方式。”她补充道：“我所做的工作和一直在做的工作都是由我致力于将创新产品推向市场并最终惠及患者的决心推动的。

I’m excited to be a part of the Company’s pioneering journey for better medicines, alongside a very impressive Board of Directors, to bring precision medicines to all patients in need.”.

我很高兴能与一个令人印象深刻的董事会一道，参与公司寻求更好药物的开创性旅程，为所有需要的患者带来精准药物。”。

Hakim Yadi PhD OBE, CEO & Co-Founder of Closed Loop Medicine, said: “On behalf of the entire team at Closed Loop, I am delighted to welcome Luba as Chair of our Board. Her impressive background and expertise in healthcare and tech, particularly as it pertains to the US market, will be instrumental in bolstering the Company’s strategic growth.

闭环医学首席执行官兼联合创始人哈基姆·亚迪博士（HakimYadi PhD-OBE）表示：“我代表闭环医学的整个团队，很高兴欢迎鲁巴担任董事会主席。她在医疗保健和技术方面的出色背景和专业知识，尤其是与美国市场相关的知识，将有助于推动公司的战略增长。

With her strong track-record of building world-class teams and companies, we are well-positioned for the commercialization of our products and the expansion of our partnerships.”.

凭借她在建立世界级团队和公司方面的良好记录，我们在产品商业化和扩大合作伙伴关系方面处于有利地位。”。